{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:41:52Z","timestamp":1780368112122,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ygyno.2009.10.070","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T09:16:31Z","timestamp":1259399791000},"page":"326-331","source":"Crossref","is-referenced-by-count":42,"title":["The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment"],"prefix":"10.1016","volume":"116","author":[{"given":"Roisin","family":"O'Cearbhaill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Iasonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martee L.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Tew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Spriggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M.","family":"Lichtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Sabbatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2009.10.070_bib1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2006.04.002","article-title":"Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients","volume":"103","author":"Navo","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2006.10.047","article-title":"Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants' Hospital","volume":"105","author":"Schwartz","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1525-1438.2007.01063.x","article-title":"Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer","volume":"18","author":"Gadducci","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2009.10.070_bib4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0959-8049(94)90489-8","article-title":"Hypersensitivity reactions to carboplatin given to patients with relapsed ovarian carcinoma","volume":"30A","author":"Morgan","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2009.10.070_bib5","unstructured":"The NCCN Clinical Practice Guidelines in Oncology\u2122 Ovarian Cancer (Version 1.2009) \u00a9 2009 National Comprehensive Cancer Network, Inc. [Cited 2009 March 24]; Available from: http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/ovarian.pdf."},{"key":"10.1016\/j.ygyno.2009.10.070_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin. Radiat. Oncol."},{"issue":"4 Pt 1","key":"10.1016\/j.ygyno.2009.10.070_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0091-6749(92)90142-O","article-title":"Anaphylaxis to carboplatin\u2014a new platinum chemotherapeutic agent","volume":"90","author":"Windom","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1991.9.3.389","article-title":"Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin","volume":"9","author":"Markman","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/sj.bmt.1701161","article-title":"Life-threatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: successful rechallenge after desensitization","volume":"21","author":"Kook","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.ygyno.2009.10.070_bib10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000055363","article-title":"Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience","volume":"61","author":"Polyzos","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.ygyno.2009.10.070_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1006\/gyno.2001.6513","article-title":"Hypersensitivity reactions to carboplatin","volume":"84","author":"Markman","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/030089169908500418","article-title":"Hypersensitivity reaction to carboplatin during treatment for ovarian cancer: successful resolution by replacement with cisplatin","volume":"85","author":"Shukunami","year":"1999","journal-title":"Tumori"},{"key":"10.1016\/j.ygyno.2009.10.070_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/gyno.2001.6519","article-title":"Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy","volume":"84","author":"Dizon","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib16","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2001.19.12.3126","article-title":"Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy","volume":"19","author":"Zanotti","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib17","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jaci.2009.02.042","article-title":"Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management","volume":"123","author":"Hesterberg","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/BF00257742","article-title":"Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II","volume":"9","author":"Calvert","year":"1982","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2222.1976.tb01897.x","article-title":"Immediate (type I) allergic responses to platinum compounds","volume":"6","author":"Cleare","year":"1976","journal-title":"Clin. Allergy"},{"issue":"15S","key":"10.1016\/j.ygyno.2009.10.070_bib20","article-title":"A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer (OC): CALYPSO study of the Gynecologic Cancer Intergroup (GCIG)","volume":"27","author":"Pujade-Lauraine","year":"2009","journal-title":"J. Clin. Oncol. (Meeting Abstracts)"},{"key":"10.1016\/j.ygyno.2009.10.070_bib21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2009.10.070_bib22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.1992.10.4.520","article-title":"Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer","volume":"10","author":"Jodrell","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00432-004-0598-z","article-title":"Thrombocytopenia associated with second-line carboplatin-based chemotherapy for ovarian, fallopian tube, and primary peritoneal cavity cancers","volume":"130","author":"Markman","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.10.070_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1179\/joc.2005.17.1.104","article-title":"Carboplatin hypersensitivity reactions: a single institution experience","volume":"17","author":"Zorzou","year":"2005","journal-title":"J. Chemother."},{"key":"10.1016\/j.ygyno.2009.10.070_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00432-003-0501-3","article-title":"Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions","volume":"130","author":"Markman","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809008890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809008890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T03:15:56Z","timestamp":1558667756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809008890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0090825809008890"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.10.070","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}